Adaptive designs for dose-finding based on efficacy–toxicity response
- 31 August 2005
- journal article
- Published by Elsevier in Journal of Statistical Planning and Inference
- Vol. 136 (6) , 1800-1823
- https://doi.org/10.1016/j.jspi.2005.08.005
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Robust Bayesian decision theory applied to optimal dosageStatistics in Medicine, 2004
- Bayesian Optimal Designs for Phase I Clinical TrialsBiometrics, 2003
- Directed Walk Designs for Dose‐Response Problems with Competing Failure ModesBiometrics, 2003
- The bivariate continual reassessment methodControlled Clinical Trials, 2002
- Model-Oriented Design of ExperimentsPublished by Springer Nature ,1997
- Some practical improvements in the continual reassessment method for phase I studiesStatistics in Medicine, 1995
- Invited Discussion Paper Constrained Optimization of Experimental DesignStatistics, 1995
- Simulation as a design tool for phase I/II clinical trials: An example from bone marrow transplantationControlled Clinical Trials, 1994
- Practical modifications of the continual reassessment method for phase i cancer clinical trialsJournal of Biopharmaceutical Statistics, 1994
- Inference and sequential designBiometrika, 1985